Lynn Kamen, Ph.D.
Scientific Officer
Lynn Kamen, Ph.D., Scientific Officer earned her Ph.D. in Immunology at the University of Michigan and completed a postdoctoral fellowship in immunology at the University of California San Francisco. Dr. Kamen has over a decade of experience working in drug development, from early target discovery through clinical development for both large and small molecules at several companies including Portola Pharmaceuticals, and Alector. More recently, she was a principal scientist at Genentech where she supported the in vitro biological characterization of large molecules and led the development of immunogenicity assays including ADA, NAb and immunogenicity risk ranking assays. Dr. Kamen is co-lead of the AAPS NAb working group.
